August 6, 2010
Botha exposes truth about HPV vaccines
Cervarix may turn out to be the
biggest medical hoax of the century should the information revealed
on a recent KRFC radio broadcast be proven true. If indeed, the
information presented during last Monday evening's broadcast is
nothing more than a worldwide exercise in profiteering.
Leslie Carol Botha regularly hosts a radio show based out of
Fort Collins, Colorado called, "Holy
Hormones, Honey - the Greatest Story Never Told." She has
been a health educator and broadcast journalist for 30 years.
On August 2, her guests were prominent cancer pathologist, Dr.
Sin Hang Lee, and Norma Erickson,
Vaccines Examiner for Examiner.com.
Leslie Carol Botha Exposes HPV
Vaccines’ Fraudulent Claims
August 02, 2010
Ms. Botha has spent a great deal of time over the last few years
investigating HPV vaccines and their effect on young women and
children around the world. Even so, the information presented during
this show shocked her beyond belief.
Leslie started her broadcast with a brief recap of facts that have
already come to light during the ongoing HPV vaccine controversy.
They are as follows:
is not a major health issue for women under good
HPV vaccines may
protect against four strains of high-risk HPV but the
duration of effectiveness is not clear; best estimates to
date are from 4 to 6 years
does not eliminate the need for traditional cervical cancer
to vaccine-relevant strains of HPV can increase the risk of
cancer by 44.6% if injected with Gardasil and 32.5% if
injected with Cervarix
HPV is not
transmitted solely via sexual contact, there are multiple
other ways to have been exposed
already 278 reports to VAERS of abnormal pap smears
Following the recap,
Norma Erickson explained the circumstances surrounding her original
contact with Dr. Lee, including a couple of statements from his
original 2007 petition to the FDA for reclassification of his HPV
test kit that brought the value of HPV vaccinations into question.
These statements were:
HPV does not
cause cervical cancer, it is the persistant infection, not
the virus, that determines the risk
93% of women
initially infected with a particular strain of HPV will not
show the same strain four menstrual cycles later
Norma also stated that
during one of her initial conversations with Dr. Lee, he had
disclosed the fact that the original studies to determine HPV type
prevalence in the U.S. had been done with self-collected specimens
by women with a Dacron swab, and that the follow-up studies of the
efficacy of the vaccines took place in Costa Rica, a country with
one of the highest cervical cancer rates in the world.
These were the
statistics used to market HPV vaccines to an American population
where women have a 14 times greater chance of dying of digestive
cancer than they do of cervical cancer.
Prominent cancer pathologist and HPV testing expert, Dr. Sin Hang
Lee, expresses his concerns regarding HPV vaccination practices
Dr. Sin Hang Lee on
Enter, Dr. Sin Hang Lee,
prominent cancer pathologist and HPV testing expert.
Dr. Lee and his
associates actually developed one of the most sensitive HPV test kit
available. This test kit, which could be used in nearly any medical
facility around the world can not only identify if HPV is present,
it will accurately determine which of the 100+ strains of
Because of a 20 year old error in FDA classification, this test
cannot be currently marketed as the virology test it is. In order to
market this test kit, the inventors must perform clinical trials, at
a cost of hundreds of thousands of dollars, to prove it can
accurately detect cancer - something it was not developed for, nor
is it intended to do.
Following is a brief summary of the critical information Dr. Lee
wants women the world over to know and understand:
cancer deaths in the United States, and developed countries,
are people who are not under regular OB/GYN care.
Cancer Institute has no data on which HPV genotypes are
prevalent in the United States.
A CDC study
showed that HPV types 16 and 18, the two HPV
vaccine-relevant strains, are NOT the prevalent types in
papers on HPV prevalence in the U.S., indicated that types
62, 84 and 52 are the most prevalent. None of these are
targeted in either approved HPV vaccine, and type 52 is an
accepted high-risk "carcinogenic" strain of HPV.
If a person has
prior exposure to vaccine-relevant HPV prior to injection,
the vaccine provides no benefit, but does provide potential
If a woman is
infected with HPV-16 in January, HPV-18 in July, and HPV-31
in December, her cancer risk is zero. Even though these are
all high risk types, they are considered transient. It takes
repeated infection by the same type to perhaps pose a risk
of cervical cancer.
Even when a
woman has persistent infection by the same type, if her
lifestyle is healthy (she does not smoke, does not take oral
contraceptives, does not have multiple sexual partners, does
not have a compromised immune system) her risk of cervical
cancer is still minimal.
HPV is not
necessarily a sexually transmittable virus--you can get it
currently spend $10 billion on unnecessary colposcopies
(cervical biopsies) every year, primarily because the
currently used HPV tests frequently display false positive
conducted by Harvard School of Public Health estimated that
95% of cervical biopsies in the United States are not
If a young woman
is considering taking an HPV vaccine, it is critical that
she know if she has been exposed to HPV, and if so, what
Nothing has been
proven to be more effective at controlling cervical cancer
than pap smear technology.
So why do HPV vaccine
manufacturers, the CDC, and the National Cancer Institute tell
physicians not to screen for HPV exposure prior to vaccination?
Unfortunately for young
women and children around the world, the answer appears to be